Compound ID | 2952
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Description: | Synthetic compound; analogue of a compound initially identified to show anti-persister activity from screening a small molecule library; reduces Pseudomonas aeruginosa persister cells in combination with ofloxacin (vs ofloxacin alone); shows intrinsic antibacterial activity (including persister cells); shows no haemolytic activity at 34 ug/ml (highest tested); shows cytotoxicity towards embryonic kidney HEK293T cells at IC50 32 ug/ml; eradicates cells when in combination with amikacin and ceftazidime |
| Year first mentioned: | 2017 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3603560 |
| Citations: |
|